Annual SG&A
$7.40 B
+$1.34 B+22.01%
31 December 2023
Summary:
Eli Lilly and Company annual selling, general & administrative expenses is currently $7.40 billion, with the most recent change of +$1.34 billion (+22.01%) on 31 December 2023. During the last 3 years, it has risen by +$1.53 billion (+26.13%). LLY annual SG&A is now -6.05% below its all-time high of $7.88 billion, reached on 31 December 2011.LLY Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$2.10 B
+$96.90 M+4.84%
30 September 2024
Summary:
Eli Lilly and Company quarterly selling, general & administrative expenses is currently $2.10 billion, with the most recent change of +$96.90 million (+4.84%) on 30 September 2024. Over the past year, it has increased by +$295.90 million (+16.40%). LLY quarterly SG&A is now -1.57% below its all-time high of $2.13 billion, reached on 31 December 2011.LLY Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$49.67 B
+$3.32 B+7.16%
30 September 2024
Summary:
Eli Lilly and Company TTM selling, general & administrative expenses is currently $49.67 billion, with the most recent change of +$3.32 billion (+7.16%) on 30 September 2024. Over the past year, it has increased by +$43.15 billion (+662.14%). LLY TTM SG&A is now -28.71% below its all-time high of $7.94 billion, reached on 31 March 2012.LLY TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.0% | +16.4% | +662.1% |
| 3 y3 years | +26.1% | +39.5% | +711.7% |
| 5 y5 years | +29.1% | +54.4% | +730.0% |
LLY Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +26.1% | at high | +65.3% | at high | +41.2% |
| 5 y | 5 years | at high | +29.1% | at high | +65.3% | at high | +160.1% |
| alltime | all time | -6.0% | +498.7% | -1.6% | +1392.4% | -28.7% | +1889.2% |
Eli Lilly And Company Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.10 B(+4.8%) | $7.40 B(+4.2%) |
| June 2024 | - | $2.00 B(+9.1%) | $7.11 B(+2.8%) |
| Mar 2024 | - | $1.84 B(+25.5%) | $6.91 B(+3.0%) |
| Dec 2023 | $7.40 B(+22.0%) | $1.46 B(-18.9%) | $6.71 B(+3.0%) |
| Sept 2023 | - | $1.80 B(-0.3%) | $6.52 B(+3.0%) |
| June 2023 | - | $1.81 B(+10.8%) | $6.33 B(+4.6%) |
| Mar 2023 | - | $1.63 B(+28.6%) | $6.05 B(+2.9%) |
| Dec 2022 | $6.07 B(-1.2%) | $1.27 B(-21.3%) | $5.88 B(-4.1%) |
| Sept 2022 | - | $1.61 B(+5.4%) | $6.13 B(+1.8%) |
| June 2022 | - | $1.53 B(+4.5%) | $6.02 B(-1.4%) |
| Mar 2022 | - | $1.46 B(-3.6%) | $6.10 B(-0.6%) |
| Dec 2021 | $6.14 B(+4.6%) | $1.52 B(+0.9%) | $6.14 B(+0.4%) |
| Sept 2021 | - | $1.51 B(-6.8%) | $6.12 B(+0.8%) |
| June 2021 | - | $1.61 B(+7.5%) | $6.07 B(+3.4%) |
| Mar 2021 | - | $1.50 B(+0.4%) | $5.87 B(-0.0%) |
| Dec 2020 | $5.87 B(-2.2%) | $1.50 B(+2.9%) | $5.87 B(-2.5%) |
| Sept 2020 | - | $1.46 B(+3.0%) | $6.02 B(+1.6%) |
| June 2020 | - | $1.41 B(-6.1%) | $5.92 B(-2.0%) |
| Mar 2020 | - | $1.50 B(-8.6%) | $6.05 B(+0.7%) |
| Dec 2019 | $6.00 B(+4.7%) | $1.65 B(+21.0%) | $6.00 B(+0.3%) |
| Sept 2019 | - | $1.36 B(-11.5%) | $5.98 B(-0.6%) |
| June 2019 | - | $1.54 B(+5.2%) | $6.02 B(+1.8%) |
| Mar 2019 | - | $1.46 B(-10.2%) | $5.91 B(+3.1%) |
| Dec 2018 | $5.73 B(-7.2%) | $1.63 B(+16.6%) | $5.73 B(+2.3%) |
| Sept 2018 | - | $1.39 B(-2.5%) | $5.60 B(-2.1%) |
| June 2018 | - | $1.43 B(+11.5%) | $5.72 B(-3.9%) |
| Mar 2018 | - | $1.28 B(-14.2%) | $5.96 B(-3.6%) |
| Dec 2017 | $6.18 B(-2.4%) | $1.49 B(-1.3%) | $6.18 B(-2.7%) |
| Sept 2017 | - | $1.51 B(-9.1%) | $6.35 B(-0.8%) |
| June 2017 | - | $1.67 B(+10.7%) | $6.40 B(+0.7%) |
| Mar 2017 | - | $1.50 B(-9.8%) | $6.36 B(+0.5%) |
| Dec 2016 | $6.33 B(-3.1%) | $1.67 B(+6.6%) | $6.33 B(-2.0%) |
| Sept 2016 | - | $1.57 B(-3.5%) | $6.46 B(-0.2%) |
| June 2016 | - | $1.62 B(+10.1%) | $6.47 B(-0.2%) |
| Mar 2016 | - | $1.47 B(-18.0%) | $6.48 B(-0.8%) |
| Dec 2015 | $6.53 B(-1.3%) | $1.80 B(+14.1%) | $6.53 B(-0.0%) |
| Sept 2015 | - | $1.58 B(-3.7%) | $6.53 B(-1.5%) |
| June 2015 | - | $1.64 B(+7.3%) | $6.63 B(-0.4%) |
| Mar 2015 | - | $1.52 B(-15.4%) | $6.66 B(+0.6%) |
| Dec 2014 | $6.62 B(-7.1%) | $1.80 B(+7.6%) | $6.62 B(-2.3%) |
| Sept 2014 | - | $1.67 B(+0.5%) | $6.77 B(+0.3%) |
| June 2014 | - | $1.66 B(+12.1%) | $6.75 B(-2.9%) |
| Mar 2014 | - | $1.48 B(-24.0%) | $6.96 B(-2.3%) |
| Dec 2013 | $7.13 B(-5.2%) | $1.95 B(+18.2%) | $7.13 B(-0.3%) |
| Sept 2013 | - | $1.65 B(-11.5%) | $7.15 B(-1.4%) |
| June 2013 | - | $1.87 B(+13.1%) | $7.25 B(-0.9%) |
| Mar 2013 | - | $1.65 B(-16.5%) | $7.32 B(-2.6%) |
| Dec 2012 | $7.51 B(-4.6%) | $1.98 B(+12.5%) | $7.51 B(-2.0%) |
| Sept 2012 | - | $1.76 B(-9.0%) | $7.67 B(-2.0%) |
| June 2012 | - | $1.93 B(+4.5%) | $7.83 B(-1.4%) |
| Mar 2012 | - | $1.85 B(-13.4%) | $7.94 B(+0.8%) |
| Dec 2011 | $7.88 B(+11.7%) | $2.13 B(+11.2%) | $7.88 B(+1.9%) |
| Sept 2011 | - | $1.92 B(-6.1%) | $7.74 B(+3.0%) |
| June 2011 | - | $2.04 B(+14.4%) | $7.51 B(+4.0%) |
| Mar 2011 | - | $1.79 B(-10.2%) | $7.22 B(+2.4%) |
| Dec 2010 | $7.05 B(+2.3%) | $1.99 B(+17.3%) | $7.05 B(+0.5%) |
| Sept 2010 | - | $1.69 B(-3.4%) | $7.02 B(-0.1%) |
| June 2010 | - | $1.76 B(+8.7%) | $7.02 B(+0.7%) |
| Mar 2010 | - | $1.61 B(-17.4%) | $6.98 B(+1.2%) |
| Dec 2009 | $6.89 B(+4.0%) | $1.95 B(+14.8%) | $6.89 B(+3.4%) |
| Sept 2009 | - | $1.70 B(-0.4%) | $6.67 B(+0.8%) |
| June 2009 | - | $1.71 B(+11.7%) | $6.61 B(+0.1%) |
| Mar 2009 | - | $1.53 B(-11.4%) | $6.61 B(-0.3%) |
| Dec 2008 | $6.63 B(+8.7%) | $1.73 B(+4.7%) | $6.63 B(-0.4%) |
| Sept 2008 | - | $1.65 B(-3.0%) | $6.66 B(+2.6%) |
| June 2008 | - | $1.70 B(+9.6%) | $6.48 B(+2.8%) |
| Mar 2008 | - | $1.55 B(-11.7%) | $6.31 B(+3.5%) |
| Dec 2007 | $6.10 B(+24.6%) | $1.76 B(+18.8%) | $6.10 B(+7.9%) |
| Sept 2007 | - | $1.48 B(-3.1%) | $5.65 B(+5.2%) |
| June 2007 | - | $1.52 B(+14.1%) | $5.37 B(+5.6%) |
| Mar 2007 | - | $1.34 B(+2.0%) | $5.08 B(+4.0%) |
| Dec 2006 | $4.89 B | $1.31 B(+9.4%) | $4.89 B(+2.5%) |
| Sept 2006 | - | $1.20 B(-3.2%) | $4.77 B(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2006 | - | $1.24 B(+8.3%) | $4.64 B(+2.0%) |
| Mar 2006 | - | $1.14 B(-3.9%) | $4.55 B(+1.2%) |
| Dec 2005 | $4.50 B(+5.0%) | $1.19 B(+11.1%) | $4.50 B(+2.1%) |
| Sept 2005 | - | $1.07 B(-6.6%) | $4.41 B(+2.8%) |
| June 2005 | - | $1.15 B(+5.1%) | $4.29 B(-0.6%) |
| Mar 2005 | - | $1.09 B(-0.7%) | $4.31 B(+0.6%) |
| Dec 2004 | $4.28 B(+5.6%) | $1.10 B(+15.4%) | $4.28 B(-0.8%) |
| Sept 2004 | - | $951.90 M(-18.7%) | $4.32 B(-0.3%) |
| June 2004 | - | $1.17 B(+10.0%) | $4.33 B(+3.0%) |
| Mar 2004 | - | $1.06 B(-6.2%) | $4.20 B(+3.7%) |
| Dec 2003 | $4.06 B(+18.4%) | $1.13 B(+17.7%) | $4.06 B(+5.6%) |
| Sept 2003 | - | $963.40 M(-7.7%) | $3.84 B(+4.1%) |
| June 2003 | - | $1.04 B(+14.1%) | $3.69 B(+3.6%) |
| Mar 2003 | - | $914.50 M(-0.7%) | $3.56 B(+4.0%) |
| Dec 2002 | $3.42 B(+0.2%) | $920.80 M(+13.6%) | $3.42 B(+1.1%) |
| Sept 2002 | - | $810.70 M(-11.4%) | $3.39 B(-1.6%) |
| June 2002 | - | $915.20 M(+17.7%) | $3.44 B(+0.4%) |
| Mar 2002 | - | $777.30 M(-11.9%) | $3.43 B(+0.2%) |
| Dec 2001 | $3.42 B(+5.9%) | $882.70 M(+1.9%) | $3.42 B(-1.8%) |
| Sept 2001 | - | $865.90 M(-3.8%) | $3.48 B(+1.9%) |
| June 2001 | - | $899.90 M(+17.0%) | $3.41 B(+3.2%) |
| Mar 2001 | - | $768.90 M(-18.6%) | $3.31 B(+2.5%) |
| Dec 2000 | $3.23 B(+17.1%) | $944.30 M(+18.0%) | $3.23 B(+4.0%) |
| Sept 2000 | - | $800.30 M(+0.6%) | $3.10 B(+3.5%) |
| June 2000 | - | $795.40 M(+15.6%) | $3.00 B(+5.1%) |
| Mar 2000 | - | $688.30 M(-15.9%) | $2.85 B(+3.5%) |
| Dec 1999 | $2.76 B(+3.7%) | $818.70 M(+17.6%) | $2.76 B(+0.3%) |
| Sept 1999 | - | $696.40 M(+7.2%) | $2.75 B(+1.1%) |
| June 1999 | - | $649.60 M(+9.6%) | $2.72 B(+0.5%) |
| Mar 1999 | - | $592.90 M(-26.8%) | $2.71 B(+1.9%) |
| Dec 1998 | $2.66 B(+19.0%) | $809.80 M(+21.3%) | $2.66 B(+8.5%) |
| Sept 1998 | - | $667.60 M(+4.7%) | $2.45 B(+3.4%) |
| June 1998 | - | $637.40 M(+17.3%) | $2.37 B(+2.8%) |
| Mar 1998 | - | $543.50 M(-9.6%) | $2.30 B(+3.2%) |
| Dec 1997 | $2.23 B(+18.0%) | $601.50 M(+2.4%) | $2.23 B(+5.7%) |
| Sept 1997 | - | $587.20 M(+2.5%) | $2.11 B(+5.7%) |
| June 1997 | - | $572.70 M(+21.4%) | $2.00 B(+4.9%) |
| Mar 1997 | - | $471.70 M(-1.8%) | $1.90 B(+0.6%) |
| Dec 1996 | $1.89 B(+2.1%) | $480.30 M(+1.5%) | $1.89 B(-4.4%) |
| Sept 1996 | - | $473.10 M(-1.2%) | $1.98 B(+1.5%) |
| June 1996 | - | $479.00 M(+4.1%) | $1.95 B(+2.2%) |
| Mar 1996 | - | $460.00 M(-18.8%) | $1.91 B(+2.8%) |
| Dec 1995 | $1.85 B(+32.6%) | $566.40 M(+27.5%) | $1.85 B(+29.8%) |
| Sept 1995 | - | $444.10 M(+1.8%) | $1.43 B(-0.8%) |
| June 1995 | - | $436.30 M(+7.1%) | $1.44 B(+0.6%) |
| Mar 1995 | - | $407.20 M(+189.4%) | $1.43 B(+2.4%) |
| Dec 1994 | $1.40 B(-63.6%) | $140.70 M(-69.1%) | $1.40 B(-56.4%) |
| Sept 1994 | - | $455.20 M(+6.3%) | $3.21 B(-5.7%) |
| June 1994 | - | $428.30 M(+14.5%) | $3.40 B(-5.7%) |
| Mar 1994 | - | $374.10 M(-80.8%) | $3.61 B(-6.0%) |
| Dec 1993 | $3.84 B(+23.3%) | $1.95 B(+200.1%) | $3.84 B(+46.8%) |
| Sept 1993 | - | $650.10 M(+2.4%) | $2.62 B(-18.7%) |
| June 1993 | - | $634.80 M(+4.9%) | $3.22 B(+1.2%) |
| Mar 1993 | - | $605.10 M(-16.7%) | $3.18 B(+2.0%) |
| Dec 1992 | $3.11 B(+35.2%) | $726.30 M(-42.0%) | $3.11 B(+2.3%) |
| Sept 1992 | - | $1.25 B(+110.2%) | $3.04 B(+30.5%) |
| June 1992 | - | $595.20 M(+9.8%) | $2.33 B(+1.6%) |
| Mar 1992 | - | $541.90 M(-17.3%) | $2.29 B(-0.4%) |
| Dec 1991 | $2.30 B(+8.2%) | $655.20 M(+21.3%) | $2.30 B(+1.4%) |
| Sept 1991 | - | $540.00 M(-3.2%) | $2.27 B(+0.1%) |
| June 1991 | - | $557.80 M(+1.4%) | $2.27 B(+2.6%) |
| Mar 1991 | - | $550.20 M(-11.8%) | $2.21 B(+3.9%) |
| Dec 1990 | $2.13 B(+21.3%) | $624.10 M(+16.2%) | $2.13 B(+11.5%) |
| Sept 1990 | - | $537.00 M(+7.2%) | $1.91 B(+4.5%) |
| June 1990 | - | $501.10 M(+7.4%) | $1.83 B(+2.3%) |
| Mar 1990 | - | $466.70 M(+15.5%) | $1.78 B(+35.4%) |
| Dec 1989 | $1.75 B(+4.1%) | $403.90 M(-11.3%) | $1.32 B(+44.2%) |
| Sept 1989 | - | $455.20 M(-0.9%) | $914.40 M(+99.1%) |
| June 1989 | - | $459.20 M | $459.20 M |
| Dec 1988 | $1.69 B(-3.4%) | - | - |
| Dec 1987 | $1.75 B(+15.3%) | - | - |
| Dec 1986 | $1.51 B(+13.8%) | - | - |
| Dec 1985 | $1.33 B(+7.6%) | - | - |
| Dec 1984 | $1.24 B | - | - |
FAQ
- What is Eli Lilly and Company annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Eli Lilly and Company?
- What is Eli Lilly and Company annual SG&A year-on-year change?
- What is Eli Lilly and Company quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly SG&A year-on-year change?
- What is Eli Lilly and Company TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Eli Lilly and Company?
- What is Eli Lilly and Company TTM SG&A year-on-year change?
What is Eli Lilly and Company annual selling, general & administrative expenses?
The current annual SG&A of LLY is $7.40 B
What is the all time high annual SG&A for Eli Lilly and Company?
Eli Lilly and Company all-time high annual selling, general & administrative expenses is $7.88 B
What is Eli Lilly and Company annual SG&A year-on-year change?
Over the past year, LLY annual selling, general & administrative expenses has changed by +$1.34 B (+22.01%)
What is Eli Lilly and Company quarterly selling, general & administrative expenses?
The current quarterly SG&A of LLY is $2.10 B
What is the all time high quarterly SG&A for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly selling, general & administrative expenses is $2.13 B
What is Eli Lilly and Company quarterly SG&A year-on-year change?
Over the past year, LLY quarterly selling, general & administrative expenses has changed by +$295.90 M (+16.40%)
What is Eli Lilly and Company TTM selling, general & administrative expenses?
The current TTM SG&A of LLY is $49.67 B
What is the all time high TTM SG&A for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM selling, general & administrative expenses is $7.94 B
What is Eli Lilly and Company TTM SG&A year-on-year change?
Over the past year, LLY TTM selling, general & administrative expenses has changed by +$43.15 B (+662.14%)